E-LIB Suche - Ergebnisse für: Tabouret, E

1

Primary central nervous system lymphoma with initial spinal..:

Harlay, V. ; Campello, C. ; Bequet, C....
Revue Neurologique. 180 (2024) 3 - p. 224-229 , 2024

Link: https://doi.org/10.1016/..

2

P12.09.B SMAC MIMETICS REPROGRAMS GLIOBLASTOMA IMMUNE LANDS..:

Snacel-Fazy, E ; Soubéran, A ; Colin, C...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii98-ii98 , 2023

Link: https://doi.org/10.1093/..

3

Innovative treatments for meningiomas:

Graillon, T. ; Tabouret, E. ; Salgues, B....
Revue Neurologique. 179 (2023) 5 - p. 449-463 , 2023

Link: https://doi.org/10.1016/..

4

Contribution of nuclear medicine to the diagnosis and manag..:

Horowitz, T. ; Tabouret, E. ; Graillon, T....
Revue Neurologique. 179 (2023) 5 - p. 394-404 , 2023

Link: https://doi.org/10.1016/..

5

KS02.5.A OVERALL SURVIVAL ASSOCIATED WITH FIRST-LINE PCV OR..:

Kacimi, S E O ; Dehais, C ; Carpentier, C...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii4-ii4 , 2023

Link: https://doi.org/10.1093/..

6

P02.09.A THE PLASTICITY AND SURVIVAL OF GLIOBLASTOMA STEM C..:

Hein, V ; Baeza-Kallee, N ; Berges, R...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii31-ii31 , 2023

Link: https://doi.org/10.1093/..

7

P14.54 Primary central nervous system lymphoma of the spina..:

Valyraki, N ; Ahle, G ; Tabouret, E...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii48-ii48 , 2021

Link: https://doi.org/10.1093/..

8

Challenges in diagnosis and management of adult spinal cord..:

Campello, C. ; Tabouret, E. ; Chinot, O.
Revue Neurologique. 177 (2021) 5 - p. 515-523 , 2021

Link: https://doi.org/10.1016/..

9

P04.08 Biopsy-only glioblastoma (BO-GBM) as a heterogeneous..:

Harlay, V ; Loundou, A ; Boucard, C...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii20-ii20 , 2021

Link: https://doi.org/10.1093/..

10

P11.04 Autonomy duration as analyzed by KPS≥70 cumulative t..:

Harlay, V ; Loundou, A ; Boucard, C...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii29-ii29 , 2021

Link: https://doi.org/10.1093/..

11

KS02.4.A Olaparib in Recurrent IDH-mutant High-Grade Glioma..:

Ducray, F ; Sanson, M ; Chinot, O...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii4-ii4 , 2021

Link: https://doi.org/10.1093/..

12

OS8.5 How to assess meningioma therapy activity: The CEVORE..:

GRAILLON, T ; Colin, T ; Peyrière, H...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii16-iii17 , 2019

Link: https://doi.org/10.1093/..

13

P14.118 Carboxypeptidase G2 (CPG2) rescue after high dose m..:

Garcilazo, Y J ; Soussain, C ; Tabouret, E...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii96-iii96 , 2019

Link: https://doi.org/10.1093/..

14

PL1.1 CDKN2A homozygous deletion is a strong adverse progno..:

Appay, R ; Dehais, C ; Colin, C...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii1-iii1 , 2019

Link: https://doi.org/10.1093/..

15

P14.76 Characteristics of anaplastic oligodendrogliomas sho..:

Garnier, L ; Dehais, C ; Curtit, E...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii85-iii85 , 2019

Link: https://doi.org/10.1093/..